Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Frontier IP supports breakthrough technology

1 Feb 2021 07:00

RNS Number : 4456N
Frontier IP Group plc
01 February 2021
 

REACH

AIM: FIPP

1 February 2021

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Frontier IP supports technology to eradicate detectable TCA from natural cork stoppers

 

 

Frontier IP, a specialist in commercialising intellectual property, notes the following release from the world's leading producer of cork products, Corticeira Amorim ("Amorim"), announcing a breakthrough technology to remove the major cause of cork taint in wine from natural corks. The move is a result of collaboration with the Group's partner university, NOVA University of Lisbon - NOVA School of Science and Technology ("FCT NOVA").

Frontier IP supported the Centro de Fisica e Investigação Tecnológica ("CEFITEC") research unit of FCT NOVA in engaging with Amorim to commercialise the new technology. The Group played an important role in negotiating the terms of the commercial agreement, including the licensing terms.

FCT NOVA's technology, branded "Naturity" by Amorim, removes the leading cause of the unpleasant tastes and odours found in corked taint, a chemical compound 2,4,6-trichloroanisole ("TCA") as well as other volatile compounds from natural corks. Naturity is based on a process that combines temperature, water and pressure without affecting the performance and integrity of the cork.

Amorim has separately developed a second technology able to reduce TCA from micro-agglomerated stoppers. These are made from tiny granules of cork bound together with specialist food-binding agents. Natural corks are made from a single piece of cork.

The technology was invented by Professor Orlando Teodoro, an expert on vacuum processes, and Professor of Engineering Physics at FCT NOVA.

Frontier IP and FCT NOVA announced their partnership to maximise the value of the university's research in September 2016. Under the terms of the agreement, Frontier IP receives an equity stake in companies created by FCT NOVA, as well as a share of the licensing revenue generated. Since the agreement was signed, three spin out companies have been created in other fields.

 

 

Neil Crabb, Frontier IP Group Chief Executive Officer, said: "It is encouraging to see this technology coming to market with the world's leading producer of cork products. More generally, we are pleased with the strong progress being made with FCT NOVA and look forward to reporting further developments from our partnership, both in terms of portfolio companies and future industrial collaborations."

Professor Orlando Teodoro, FCT NOVA, said: "The technology is a notable example of Engineering Physics which aims to transfer standard technologies in research labs to the industry, solving real problems or improving industry competitiveness and innovation. The outside view we brought to the problem was the key to its solution."

 

Amorim statement begins:

Amorim reveals breakthrough technologies to eradicate detectable TCA

· The world's greenest, most efficient anti-TCA technologies are launched simultaneously for both natural whole corks and technical cork stoppers

Amorim, the world's leading producer of cork products, announced today the launch of Naturity and Xpür, technologies designed to remove detectable TCA from natural corks and to create a new segment of micro-agglomerated stoppers, respectively.

Research for the patent-pending Naturity technology began in 2016 with the NOVA School of Science and Technology, and is based on the principles of thermal desorption through a proprietary, non-sequential use of pressure, temperature, purified water and time. No artificial elements are used in the process, which facilitates the extraction of 150+ volatile compounds, including TCA. Launching in USA and worldwide, Naturity expands non-detectable TCA performance in the natural cork product segment, while further strengthening the operational deliverables of NDTech, the advanced screening service that individually analyzes and removes any natural cork with more than 0.5 nanograms per liter (ng/L) of TCA*.

Extensive bottling trials with various wineries have yielded exemplary results in measuring the treatment's impact on cork performance, with additional third-party validation trials to be conducted as soon as possible with the Geisenheim Institute in Germany and the Campden & Chorleywood labs in the UK.

Another development announced today is Amorim's Xpür technology, developed to expand the non-detectable TCA performance for micro-agglomerated stoppers. Xpür improves upon the conventional supercritical CO2 application developed several decades ago, reengineering and upgrading the concept with 21st-century technology. Amorim's new, innovative take on the system uses only 25% of the energy and just 10% of the CO2 previously required.

Furthermore, Xpür achieves results of TCA reduction levels to 0.3 ng/L in treated micro-agglomerated stoppers, while leaving the physical-mechanical properties of cork intact. As a result, Amorim's range of micro-agglomerated corks features the highest possible percentage of cork and do not require additional chemical solutions to maintain cork's natural properties, namely the all-important compressibility and expansion rates.

Xpür will be employed in the treatment of technical stoppers Neutrocork Premium and QORK - the latter employing an innovative binding agent made using 100% polyols from vegetable origin, and which is expected to reduce the amount of single-use plastic stoppers in the world by several million units.

Commenting on this important landmark, António Amorim, Chairman and CEO, noted that: "These technologies come as a result of robust financial investments, time, and dedication to R&D from our team. Despite the obstacles of 2020, we were able to fulfill the promise we made to have non-detectable TCA performance for all the cork stopper segments by the end of the year. This is our commitment to our 30,000 customers around the world - to guarantee the quality and consistency of their products and ensure that consumers' preference for cork will only grow stronger."

Amorim statement ends

 

ENQUIRIES

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / George Payne

 

 

 

 

 

 

 

ABOUT CORTICEIRA AMORIM

Corticeira Amorim is the world's largest cork processing group with annual sales topping 780 million euros. Founded in 1870, the company currently has dozens of business units distributed across five continents. It exports numerous products to more than 100 countries and has a diversified network of 30,000 customers. With strong sustainability credentials and a negative carbon footprint, Corticeira Amorim provides a set of solutions, materials and applications to some of the world's most technological, disruptive and demanding activities, such as the aerospace, automobile, wine and spirits, construction, sports, energy and interior and product design. www.amorimcork.com

 

ABout frontier IP Group

Frontier IP unites science, finance and industry to build businesses based on outstanding research. It identifies strong intellectual property and accelerates its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

ABOUT FCT NOVA

The NOVA School of Science and Technology (FCT NOVA) is one of the three largest and most prestigious schools of Engineering and Sciences in Portugal.

FCT NOVA, with about 8000 students, is located in one of the best university campuses, and is distinguished by a culture of the excellent teacher-student relationship and intense academic life. It conduced to a scientific performance that allows the school to integrate the main technological international university networks and participate in key consortiums with European and US universities.

FCT NOVA hosts CEFITEC, which is the Center for Physics and Technological Research, as one of its research units. CEFITEC's research is focused on Experimental and Engineering Physics in topics of surface science, vacuum metrology, optics, solid state sensors and molecular physics.

The Innovation, Research & Impact Strategy Office (IRIS) cooperates with Frontier IP supporting the research & innovation cycle of FCT NOVA scientific community, from the idea to its market application, fostering sustainable knowledge generation to increase the School's societal and economic impact.

 

ABOUT REACH ANNOUNCEMENTS

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKVBRANUAUAR
Date   Source Headline
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSGrant of Options
6th Dec 20196:25 pmRNSHolding(s) in Company
5th Dec 201912:00 pmRNSHolding(s) in Company
4th Dec 201912:00 pmRNSResult of AGM & Total Voting Rights
26th Nov 201912:58 pmRNSHolding(s) in Company
13th Nov 20195:00 pmRNSPosting of Annual Report and Accounts
7th Nov 201912:20 pmRNSHolding(s) in Company
6th Nov 20192:00 pmRNSResult of Placing
6th Nov 20197:01 amRNSProposed fundraising of £3.5m by way of Placing
6th Nov 20197:00 amRNSFinal Results
22nd Oct 20197:00 amRNSAppointment of senior advisers
15th Oct 20197:00 amRNSNew portfolio company: Elute Intelligence Holdings
10th Sep 20197:00 amRNSAppointment of Broker
25th Jul 20197:00 amRNSExscientia collaboration with Rallybio
15th Jul 201912:08 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSExscientia partnership with GT Apeiron
31st May 20195:00 pmRNSTotal Voting Rights
31st May 20193:15 pmRNSDirectorate Change
28th May 20197:00 amRNSFieldwork Robotics completes initial field trials
15th May 20197:00 amRNSDirector exercise of options, shareholding and TVR
10th May 201911:48 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSEuropean plan to boost marine & coastal economies
8th Apr 20197:00 amRNSParkside Architectural Tiles launch Alusid range
8th Apr 20197:00 amRNSInvestor event at the Royal Academy of Engineering
8th Apr 20197:00 amRNSBosch UK to work with Pulsiv Solar
4th Apr 20197:00 amRNSExscientia reaches first major milestone with GSK
3rd Apr 20195:51 pmRNSHolding(s) in Company
3rd Apr 20193:45 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSFieldwork Robotics wins Innovate UK ISCF grant
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20191:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.